Professor Ilias Goranitis is the inaugural Head of the Economics of
Genomics and Precision Medicine Unit and Deputy Head of Melbourne
Health Economics within the Centre for Health Policy at the University
of Melbourne. He led the health economics program of Australian
Genomics (2018 to 2025).
His main applied and methodological work focuses on exploring the value
and cost-effectiveness of genomic technologies using health economic
and discrete choice modelling.
Prof Goranitis has been a successful co-applicant in research grants
nationally (MRFF, NHMRC and the Department of Health) and
internationally (UK NIHR, the UK Department of Health, and the Gates
Foundation) worth more than $123 million across 40+ funded grants. His
work has informed national
health policy and international guidelines, and has been published in
top-tier clinical and health economics journals.
Prof Goranitis was awarded the 2024 Deeble-Scotton Prize for Policy
Impact from the Australian Health Economics Society and a Dame Kate
Campbell Dean’s Fellowship from the Faculty of Medicine, Dentistry
and Health Sciences at the University of Melbourne, which recognises and
rewards outstanding research performance and demonstration of Faculty
values. He was listed in the world’s top 2% scientists list
published by the Stanford University and Elsevier.
With his team, Prof Goranitis led the health economics evidence review
to inform Cancer Australia’s National Framework for Genomics in
Cancer Control and WHO’s investment case in human genomics. He has
been invited to present his work at the World Health Organization Expert
Meeting on ‘Accelerating access to human genomics for public
health’ (2024), the Global Alliance for Genomics and Health
National Initiatives Forum (2024) and 14th Plenary meeting (2026), the
European Society of Human Genetics conference (2023 and 2026), the
Human Genetics Society of Australasia
meeting (2023), and the World Economic Forum Expert Meeting on
‘The economics of global data access for solving rare
diseases’ (2020).
He is a Founding and Lead Convener of the Economics of Genomics &
Precision Medicine (Econ-Omics) special interest group within the
international Health Economics Association and a member of the Global
Economics and Evaluation of Clinical Genomics Sequencing Working Group.
Prof Goranitis has led guest editorials on topics related to health
economics and genomics for the Applied Health Economics and Health
Policy journal and the Journal of Community Genetics.
Prof Goranitis has significant experience in teaching and leading the
delivery of health economics related subjects to undergraduate economics
and postgraduate health economics and public health students. He holds
honorary appointments with the Murdoch Children’s Research
Institute, and he is an alumnus of the London School of Economics and
University of Athens.
